Ryan Merkow to Prognosis
This is a "connection" page, showing publications Ryan Merkow has written about Prognosis.
Connection Strength
0.511
-
Pre-Operative, Intra-Operative, and Post-Operative Factors Associated with Post-Discharge Venous Thromboembolism Following Colorectal Cancer Resection. J Gastrointest Surg. 2020 01; 24(1):144-154.
Score: 0.095
-
National assessment of margin status as a quality indicator after pancreatic cancer surgery. Ann Surg Oncol. 2014 Apr; 21(4):1067-74.
Score: 0.064
-
Importance of and adherence to lymph node staging standards in gastrointestinal cancer. Surg Oncol Clin N Am. 2012 Jul; 21(3):407-16, viii.
Score: 0.058
-
Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States. Cancer. 2012 Jul 01; 118(13):3268-76.
Score: 0.055
-
American College of Surgeons survival calculator for biliary tract cancers: using machine learning to individualize predictions. Surgery. 2025 Feb; 178:108919.
Score: 0.034
-
Association of Hospital Volume With Quality Care Outcomes Following Minor and Major Hepatectomy for Primary Liver Cancer. J Surg Oncol. 2024 Oct; 130(5):1033-1041.
Score: 0.034
-
Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network. Ann Surg Oncol. 2023 Nov; 30(12):7362-7370.
Score: 0.031
-
National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection. Ann Surg Oncol. 2020 Mar; 27(3):909-918.
Score: 0.024
-
National practice patterns of completion lymph node dissection for sentinel node-positive melanoma. J Surg Oncol. 2018 Sep; 118(3):493-500.
Score: 0.022
-
An opportunity to ensure high-quality melanoma care through the use of a preoperative treatment algorithm. Ann Surg Oncol. 2013 Nov; 20(12):3976-83.
Score: 0.016
-
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.
Score: 0.015
-
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement. Ann Surg Oncol. 2012 Nov; 19(12):3659-67.
Score: 0.015
-
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States. Ann Surg Oncol. 2013 Feb; 20(2):362-70.
Score: 0.015
-
Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States. Ann Surg Oncol. 2012 Jan; 19(1):184-91.
Score: 0.014
-
Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J Gastrointest Surg. 2007 Nov; 11(11):1460-7; discussion 1467-9.
Score: 0.010
-
Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg. 2006 Dec; 192(6):878-81.
Score: 0.010